| 甘草酸镁联合丁二磺酸腺苷蛋氨酸治疗药物性肝损伤患者疗效研究 |
| |
| 引用本文： | 林成,王同彪,李岳勇,李龙华. 甘草酸镁联合丁二磺酸腺苷蛋氨酸治疗药物性肝损伤患者疗效研究[J]. 实用肝脏病杂志, 2021, 24(2): 232-235. DOI: 10.3969/j.issn.1672-5069.2021.02.021 |
| |
| 作者姓名： | 林成 王同彪 李岳勇 李龙华 |
| |
| 作者单位： | 533000 广西壮族自治区白色市 右江民族医学院附属医院介入肿瘤科(林成,李岳勇,李龙华); 广西中医药大学第一附属医院肿瘤科(王同彪) |
| |
| 摘 要： | 目的 观察应用异甘草酸镁联合丁二磺酸腺苷蛋氨酸治疗药物性肝损伤(DILI)患者的疗效及血清血红素单加氧酶1(HO-1)、核因子E2相关因子2(Nrf-2)和谷胱甘肽过氧化物酶(GSH-Px)水平的变化.方法 2018年1月 ～2019年12月我院收治的78例DILI患者,采用随机数字表法将患者分为对照组和联合组,各39...
|
| 关 键 词： | 药物性肝损伤 异甘草酸镁 丁二磺酸腺苷蛋氨酸 血红素单加氧酶1 核因子E2相关因子2 谷胱甘肽过氧化物酶 治疗 |
| 收稿时间： | 2020-07-23 |
Short-term efficacy of magnesium isoglycyrrhizinate and adenosylmethionine butanedisulfonate combination in treatment of patients with drug-induced liver injury |
| |
| Lin Cheng,Wang Tongbiao,Li Yueyong,et al. Short-term efficacy of magnesium isoglycyrrhizinate and adenosylmethionine butanedisulfonate combination in treatment of patients with drug-induced liver injury[J]. Journal of Clinical Hepatology, 2021, 24(2): 232-235. DOI: 10.3969/j.issn.1672-5069.2021.02.021 |
| |
| Authors: | Lin Cheng Wang Tongbiao Li Yueyong et al |
| |
| Affiliation: | Department of Intervention, Affiliated Hospital, Youjiang Nationality Medical College, Baise 533000,Guangxi Zhuang Autonomous Region, China |
| |
| Abstract: | Objective The aim of this study was to investigate the short-term efficacy of magnesium isoglycyrrhizinate and adenosylmethionine butanedisulfonate combination in treatment of patients with drug-induced liver injury(DILI)and serum heme monooxygenase 1(HO-1),nuclear factor E2 related factor 2(Nrf-2)and glutathione peroxidase(GSH-Px)level changes.Methods 78 patients with DILI were enrolled in this study between January 2018 and December 2019,and were randomly divided into control and combination groups,with 39 cases in each group.The patients in control group received intravenous infusion of adenosylmethionine butanedisulfonate,and those in the combination received intravenous infusion of magnesium isoglycyrrhizinate at the base of medicine in the control for two weeks.Serum Nrf-2,TNF-α,IL-10,NO,NOS,HO-1,GSH-Px and macrophage dectected.Results At the end two week migration inhibitory factor(MIF)were of treatment,serum alanine aminotransaminase level in the combination group was(65.9±7.7)U/L,serum AST level was(58.5±7.3)U/L,and serum total bilirubin level was(20.5±5.3)μmol/L,all significantly lower than【(93.5±11.2)U/L,(91.3±10.8)U/L and(25.2±7.9)μmol/L,respectively,P<0.05】in the control;serum NOS level was(47.7±5.8)U/mg,and serum GSH-Px level was(0.8±0.1)ng/mL,both significantly higher than【(38.5±5.6)U/mg and(0.5±0.1)U/mg,respectively,P<0.05】,while serum HO-1 level was(0.4±0.1)ng/mL,and serum Nrf-2 level was(0.5±0.1)ng/mL,both significantly lower than【(0.7±0.1)ng/mL and(0.8±0.1)U/mg,respectively,P<0.05】in the control;serum TNF-αlevel was(3.0±0.5)ng/mL,and serum MIF level was(8.9±1.1)ng/mL,significantly lower than【(4.2±0.6)ng/mL and(11.4±1.5)ng/mL,respectively,P<0.05】,while serum IL-10 level was(33.1±4.4)pg/mL,and serum NO level was(66.5±7.3)μmol/L,significantly higher than【(22.5±2.9)pg/mL and(41.1±5.6)μmol/L,respectively,P<0.05】in the control.Conclusion The magnesium isoglycyrrhizinate and adenosylmethionine butanedisulfonate combination in the treatment of patients with DILI have a short-term efficacy,which might be related to the inhibition of inflammatory and oxidative stress reactions,and needs further clinical investigation. |
| |
| Keywords: | Drug-induced liver injury Magnesium isoglycyrrhizinate Adenosylmethionine butanedisulfonate Heme monooxygenase 1 Nuclear factor E2 related factor 2 Glutathione peroxidase Therapy |
| 本文献已被 CNKI 维普 等数据库收录！ |
| 点击此处可从《实用肝脏病杂志》浏览原始摘要信息 |
|
点击此处可从《实用肝脏病杂志》下载免费的PDF全文 |
|
